Biology subjects

Froehlich, M.

Publications and source records attributed to Froehlich, M..

5 recordsLinked to original sources

bioRxiv2024

Sumatran orangutan mothers differ in the extent and trajectory of their expression of maternal behaviour

Mothers play a crucial role in the early development and survival of mammalian offspring, and differences in maternal care may differentially affect offsprings development. Whereas previous research has primarily focused on biological and socioecological factors to understand population-level variation in maternal behaviour, the individual as a source of variation remains understudied. We investigated between-individual variation in the average expression of, and plasticity in, six maternal behaviours in Sumatran orangutans, using 15 years of behavioural data. We found that mothers differed substantially in the average expression of four maternal behaviours, even after controlling for socioecological conditions, biological state characteristics, and the offsprings influence on these behaviours. Furthermore, not controlling for these confounding effects exaggerated or masked between-individual variation. Mothers also substantially differed in how they adjusted three of the maternal behaviours during offspring development, meaning that mothers differed in behavioural plasticity. Our results suggest that Sumatran orangutan mothers are constrained in the average expression of maternal behaviours and their plastic responses, potentially resulting in consistent differences among mothers, otherwise called maternal personality. Our findings highlight that individual variation around the population mean in maternal behaviour is more than noise and presents opportunities to study novel evolutionary processes that shape maternal behaviour.

animal behavior and cognition↗

bioRxiv2023

ZygosityPredictor

SummaryZygosityPredictor provides functionality to evaluate how many copies of a gene are affected by mutations in next generation sequencing data. In cancer samples, the tool processes both somatic and germline mutations. In particular, ZygosityPredictor computes the number of affected copies for single nucleotide variants and small insertions and deletions (Indels). In addition, the tool integrates information at gene level via phasing of several variants and subsequent logic to derive how strongly a gene is affected by mutations and provides a measure of confidence. This information is of particular interest in precision oncology, e.g. when assessing whether unmutated copies of tumor-suppressor genes remain. Availability and implementationZygosityPredictor was implemented as an R-package and is available via Bioconductor at https://bioconductor.org/packages/ZygosityPredictor. Detailed documentation is provided in the vignette including application to an example genome.

bioinformatics↗

bioRxiv2022

Small Molecule Assembly Modulators with Pan-Cancer Therapeutic Efficacy

Two structurally-unrelated small molecule chemotypes, represented by compounds PAV-617 and PAV-951 with antiviral activity in cell culture against monkeypox virus (MPXV) and human immunodeficiency virus (HIV) respectively, were studied for anti-cancer efficacy. Each exhibited apparent pan-cancer cytotoxicity, reasonable pharmacokinetics, and non-toxicity in mice at active concentrations. Anti-tumor properties of both chemotypes, were validated in mouse xenografts against A549 human lung cancer and, for one of the chemotypes, against HT-29 colorectal cancer. The targets of these compounds are unconventional: each binds to a different transient, energy-dependent multi-protein complex containing the protein TRIM28/KAP1, an allosteric modulator known to regulate mechanisms underlying viral and nonviral disease states including cancer. Treatment with these compounds alters the target multi-protein complexes in a manner consistent with allosteric modulation as their mechanism of action. These compounds appear to remove a block, crucial for cancer survival and progression, on the homeostatic linkage of uncontrolled cellular proliferation to apoptosis. These compounds provide starting points for development of next-generation non-toxic, pan-cancer therapeutics.

cancer biology↗

bioRxiv2021

Wild-captive contrasts in non-vocal communicative repertoires and functional specificity in orang-utans

The creation of novel communicative acts is an essential element of human language. Although some research suggests the presence of this ability in great apes, this claim remains controversial. Here, we use orang-utans (Pongo spp.) to systematically assess the effect of the wild-captive contrast on the repertoire size of communicative acts. We find that individual communicative repertoires are significantly larger in captive compared to wild settings, irrespective of species, age-sex class or sampling effort. Twenty percent of the orang-utan repertoire in captivity were not observed in the wild. In Sumatran orang-utans, the more sociable species, functional specificity was also higher in captive versus wild settings. We thus conclude that orang-utans, when exposed to a more sociable and terrestrial lifestyle, have the behavioural plasticity to invent new communicative behaviours that are highly functionally specific. This productive capacity by great apes is a major prerequisite for the evolution of language and seems to be ancestral in the hominid lineage.

animal behavior and cognition↗

bioRxiv2021

From COVID-19 to the Common Cold: Novel Host-Targeted, Pan-Respiratory Antiviral Small Molecule Therapeutics

We present a novel small molecule antiviral chemotype that was identified by an unconventional cell-free protein synthesis and assembly-based phenotypic screen for modulation of viral capsid assembly. Activity of PAV-431, a representative compound from the series, has been validated against infectious virus in multiple cell culture models for all six families of viruses causing most respiratory disease in humans. In animals this chemotype has been demonstrated efficacious for Porcine Epidemic Diarrhea Virus (a coronavirus) and Respiratory Syncytial Virus (a paramyxovirus). PAV-431 is shown to bind to the protein 14-3-3, a known allosteric modulator. However, it only appears to target the small subset of 14-3-3 which is present in a dynamic multi-protein complex whose components include proteins implicated in viral lifecycles and in innate immunity. The composition of this target multi-protein complex appears to be modified upon viral infection and largely restored by PAV-431 treatment. Our findings suggest a new paradigm for understanding, and drugging, the host-virus interface, which leads to a new clinical therapeutic strategy for treatment of respiratory viral disease.

biochemistry↗